US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi NVO 2x Daily ETF

14.67

+0.30012.09%

Volume:2K

Turnover:29.30K

Market Cap:220.00K

PE:- -

High:14.67

Open:14.48

Low:14.48

Close:14.37

52wk High:27.19

52wk Low:13.75

Shares:15.00K

Float Shares:15.00K

Volume Ratio:5.79

T/O Rate:13.49%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement

One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model

AI Industry Frontlines

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement

Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays

Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline

Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market

Moderately bullish activity in Novo Nordisk with shares up 0.39%

Major Drugmakers Turn to China for Licensing Deals

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

23% Weight Loss, 27% Dropouts: How Strong Is Lilly's Phase 2 Combo, Really?

Options & Short Sell

Moderately bullish activity in Novo Nordisk with shares down 1.06%

Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study

Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise

Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Novo Nordisk announces new data on CagriSema

Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study

2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/NVOC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","market":"US","secType":"STK","nameCN":"Corgi NVO 2x Daily ETF","latestPrice":14.6667,"timestamp":1791576000000,"preClose":14.3666,"halted":0,"volume":2023,"delay":0,"changeRate":0.02088872802193981,"floatShares":15000,"shares":15000,"eps":0,"marketStatus":"Market Closed","change":0.3001,"latestTime":"10-09 16:00:00 EDT","open":14.48,"high":14.6667,"low":14.48,"amount":29296,"amplitude":0.012995,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"listingDate":1784001600000,"exchange":"CBOE","adjPreClose":14.3666,"nav":14.35,"aum":215250,"bidAskSpread":0,"volumeRatio":5.793239},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOC\",,,,,undefined,":{"symbol":"NVOC","floatShares":15000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":5.793239,"shares":15000,"dividePrice":0,"high":14.6667,"amplitude":0.012995,"preClose":14.3666,"low":14.48,"week52Low":13.7479,"pbRate":"--","week52High":27.1863,"institutionHeld":0,"latestPrice":14.6667,"eps":0,"divideRate":0,"volume":2023,"delay":0,"ttmEps":0,"open":14.48,"prevYearClose":24.92,"prevWeekClose":13.7479,"prevMonthClose":14.2471,"prevQuarterClose":14.2471,"fiveDayClose":13.7479,"twentyDayClose":18.6239,"sixtyDayClose":27.1863},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOC\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1157208455","title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","url":"https://stock-news.laohu8.com/highlight/detail?id=1157208455","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157208455?lang=en_us&edition=fundamental","pubTime":"2026-10-05 10:38","pubTimestamp":1791167898,"startTime":"0","endTime":"0","summary":"","market":"uk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3125.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","GSK","AMGN","JNJ","BMY","LLY","NVAX","VIR","LLII","BNTX","ABT","AZN","NVOX","NVO","LLYX","REGN","VERU","ELIL","MRK","MRNY","PFE","ABBV","NVOC","MRNA","SNY","MRNX","BIIB","CSLLY","NVOH","GILD","GSKH","NVS"],"isVideo":true,"video":{"duration":229,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3125.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3125.webp","audio_url":"https://static.tigerbbs.com/c84a44b957cb1cda4f39d165f739b07a.mp3","isAI":true},"gpt_icon":0},{"id":"1181200013","title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","url":"https://stock-news.laohu8.com/highlight/detail?id=1181200013","media":"AI Industry Frontlines","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181200013?lang=en_us&edition=fundamental","pubTime":"2026-10-03 18:15","pubTimestamp":1791022548,"startTime":"0","endTime":"0","summary":"","market":"hk","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3089.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"One Weekend, Thousands Of Compounds: Inside Microsoft's New AI Biology Model","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDY","ELIS","GOU","MSFL","NVDB","NVDQ","NVDS","NVOH","GOOY","NVYY","NVC","NVII","NVDD","GGLL","GOOX","MSFC","DIPS","GOOGL","MSFU","RXRX","NVDU","07388","MSFO","GOGL","JNJ","NVDL","07788","LLYX","NVDX","GOOW","NVD","ARKG","MSFW","NVO","GOOP","IBB","NVDA","NVOC","LLII","AIQ","GGLS","MSFT","NVDW","NVOX","SDGR","ANV","MSFY","MSFX","LLY","GOOL","NVS","MSFD","NVDO","NVDG","ELIL"],"isVideo":true,"video":{"duration":212,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/render_3089_1791021487749.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3089.webp","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/3089/tts/voiceover_b9d2a6cae7d8b2cb.mp3","isAI":true},"gpt_icon":0},{"id":"1151971109","title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=1151971109","media":"Macro World","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151971109?lang=en_us&edition=fundamental","pubTime":"2026-10-03 17:22","pubTimestamp":1791019366,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3081.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JNJ","AZN","MRNY","SNY","LLYX","MRK","GSK","NVS","MRNA","ABBV","NVOH","BAYRY","BNTX","ABT","BMY","GSKH","NVAX","REGN","ELIS","LLII","MRNX","NVO","NVOX","BIIB","NVOC","AMGN","ELIL","LLY","VIR","VERU","GILD","PFE"],"isVideo":true,"video":{"duration":206,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3081.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3081.webp","audio_url":"https://static.tigerbbs.com/f1bbc2b54742b92aafc704bc4d0c576c.mp3","isAI":true},"gpt_icon":0},{"id":"1198460816","title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","url":"https://stock-news.laohu8.com/highlight/detail?id=1198460816","media":"Bellwether Stocks Movement","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198460816?lang=en_us&edition=fundamental","pubTime":"2026-10-03 16:06","pubTimestamp":1791014787,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3076.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","MRNY","ELIS","NVAX","AMGN","LLII","REGN","BIIB","BNTX","NVOH","ABT","BMY","JNJ","NVO","AZN","ABBV","SNY","NVOC","MRNA","VIR","NVS","MRNX","GSK","VERU","ELIL","LLY","GSKH","LLYX","MRK","GILD","PFE"],"isVideo":true,"video":{"duration":261,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3076.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3076.webp","audio_url":"https://static.tigerbbs.com/5f9a45d52af3674e966786287f89b42c.mp3","isAI":true},"gpt_icon":0},{"id":"2672741768","title":"Novo Nordisk Says FDA Review of Hemophilia Drug is Hitting Delays","url":"https://stock-news.laohu8.com/highlight/detail?id=2672741768","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672741768?lang=en_us&edition=fundamental","pubTime":"2026-10-03 06:13","pubTimestamp":1790979180,"startTime":"0","endTime":"0","summary":"Novo Nordisk received notice from the Food and Drug Administration that its review of denecimig for the treatment of hemophilia A is still ongoing.The FDA hasn't communicated a new timeline for expected regulatory action on the biologics license application, the drug company said Friday.The cause for the extension of the agency's review is ongoing remediation activities at Novo's manufacturing facility. The FDA performed a pre-license inspection of the site and provided feedback after the company first submitted its license application.Novo submitted the application to the FDA in September 2025 for denecimig as a treatment of hemophilia A in adult and pediatric patients. At that time, it was anticipating a regulatory decision in the third quarter of 2026.The FDA hasn't identified deficiencies related to the clinical efficacy or safety data of the drug, Novo said. The company is continuing implementation of the facility remediation activities in response to the FDA's feedback.The prolon","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU1093756168.USD","THNR","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOH","OZEM","PPH","BK4532","BK4588","NVOC","LU1093756325.SGD","NVOX","NVO","BK4007","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672743136","title":"Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2672743136","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672743136?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:31","pubTimestamp":1790958671,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. The study Investigating the Effect of Post-dose Meal Timings and Water Vol...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-zenagamtide-dosing-to-sharpen-its-obesity-drug-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756168.USD","THNR","BK4585","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","NVOH","OZEM","PPH","BK4532","BK4588","NVOC","LU1093756325.SGD","NVOX","NVO","BK4007","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672574802","title":"Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672574802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672574802?lang=en_us&edition=fundamental","pubTime":"2026-10-03 00:03","pubTimestamp":1790956980,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B shed 0.5% to DKK248.75 Friday on what proved to be an overall positive trading session for the stock market, with the OMX Nordic 40 Index rising 1.1% to 2,596.93.This was the stock's second consecutive day of losses.The company closed DKK161.20 short of its 52-week high of DKK409.95, which the company achieved on January 23, 2026.Trading volume was 4,305,929, compared to the 50-day average trading volume of 4,898,141.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4599","BK4588","LU1093756168.USD","NVOH","OZEM","IE00BZ1G4Q59.USD","THNR","BK4007","LU0154236417.USD","NVO","LU1093756325.SGD","NVOC","NVOX","PPH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672103127","title":"Moderately bullish activity in Novo Nordisk with shares up 0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672103127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672103127?lang=en_us&edition=fundamental","pubTime":"2026-10-02 22:15","pubTimestamp":1790950515,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares up 14c, or 0.39%, near $37.55. Options volume relatively light with 6894 contracts t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-0-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-up-0-39-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4599","BK4588","LU1093756168.USD","NVOH","OZEM","IE00BZ1G4Q59.USD","THNR","BK4007","LU0154236417.USD","NVO","LU1093756325.SGD","NVOC","NVOX","PPH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672715686","title":"Major Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2672715686","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672715686?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:50","pubTimestamp":1790934645,"startTime":"0","endTime":"0","summary":"FACTBOX-Major drugmakers turn to China for licensing dealsOct 2 (Reuters)-Abogen said on Friday it has signed a licensing deal worth up to $7.8 billion with Swiss drugmaker NovartisNOVN.Sto develop an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nL4N45O0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2360032135.SGD","LU1481599808.USD","LU0122379950.USD","LU0234570918.USD","LU1551013425.SGD","LU1066051498.USD","02096","BK0196","LU0354030511.USD","03933","LU0053666078.USD","LU2213496289.HKD","LU2357627491.SGD","LU0149534421.HKD","LU0203201768.USD","LU0234572021.USD","BK4559","LU1267930227.SGD","BK4585","LU1989772923.USD","LU1655091616.SGD","SG9999018865.SGD","LU2324357040.USD","LU2114397693.USD","LU1116320901.HKD","SG9999003800.SGD","LU0708995401.HKD","LU1923622614.USD","IE00B1XK9C88.USD","LU0109981661.USD","LU1868836757.USD","LU1146622755.USD","PPH","SG9999004220.SGD","LU0496365809.HKD","LU0965509010.AUD","LU1261432733.SGD","LU2491050071.SGD","LU1894683348.USD","LU1078025761.USD","LU0795875086.SGD","LU2399975544.HKD","LU0882574055.USD","LU1226287792.SGD","BK4566","LU2495084118.USD","LU0976567544.SGD","LU0889566641.SGD","LU1309081286.SGD","LU2580892862.HKD","LU1267930573.SGD","LU1781817850.SGD","LU1291159041.SGD","LU0315179316.USD","LU0575583348.USD","LU0109394709.USD","PFE","LU1064927863.SGD","IE00BBT3K403.USD","LU1670628061.USD","TRUH","LU0634319403.HKD","LU0882574139.USD","LU1019634622.SGD","LU1202635105.USD","LU0133085943.USD","LU1934455194.USD","LU1170363599.USD","LU1941712264.USD","LU0960981461.USD","KURE","IE00BKDWB100.SGD","LU1003076772.USD","LU2039709279.SGD","LU0477156953.USD","IE000WAW04H5.SGD","LU0348827113.USD","LU0130102774.USD","LU0310800379.SGD","IE00BDGV0183.EUR","LU2097828805.USD","IE00BFTCPJ56.SGD","LU0823434740.USD","LU2125909593.SGD","LU1969619763.USD","LU1127390331.HKD","LU1064130708.USD","LU2089984988.USD","LU0868494617.USD","LU2129689431.USD","09995","LU0963555726.SGD","LU1496350171.SGD","SG9999001440.SGD","LU1066051811.HKD","LU2750360997.AUD","LU0502904849.HKD","GLAM","IE00B4JS1V06.HKD","LU2552382132.HKD","LU2347655156.SGD","LU0553294199.USD","LU0106261372.USD","LU1400636657.SGD","LU1712237335.SGD","LU2539964713.USD","LU0395794307.EUR","LU1548497426.USD","LU0823399737.USD","ILDR","LU0079474960.USD","LU2362540622.SGD","LU2491049909.HKD","LU0969580561.USD","LU2023251221.USD","LU2111349929.HKD","THNR","BK4532","IE00BN29S564.USD","LU1226287529.USD","IE0002270589.USD","LU0889565080.SGD","LU1064131342.USD","LU2063271972.USD","LU2646069778.SGD","BK1589","LU2293690082.USD","IE00B3T34201.USD","LU2108987350.USD","IE00BFXG1179.USD","IXJ","IE000SO60NU8.SGD","LU0203347892.USD","BK0012","SMMT","01276","LU0326950275.SGD","LU0971552830.HKD","LU2896262040.SGD","BK4548","LU1098665638.USD","LU2125154778.USD","LU1093756325.SGD","LU1228905037.USD","LU0128525929.USD","CURE","LU1037948541.HKD","LU0784383803.USD","LU0114720955.EUR","MRK","LU0672654240.SGD","LU0949170772.SGD","LU0868494708.USD","LU1236620834.HKD","LU2279689827.SGD","LU2289578879.USD","LU2168563687.JPY","01530","IE00BN8TJ469.HKD","LU1496350502.SGD","IE000M9KFDE8.USD","LU0130517989.USD","LU1328277881.USD","IE00BLSP4239.USD","LU0171276677.USD","IE00BJJMRZ35.SGD","LU1046248800.SGD","LU0256863811.USD","IE0008368742.USD","LU0708994859.HKD","LU2129689514.USD","LU0323591593.USD","LU2242646821.SGD","LU0689472784.USD","LU0965509101.SGD","BK4535","LU0077335932.USD","LU1019632923.USD","LU0561508036.HKD","LU2293690249.USD","BK1191","LU0098860793.USD","LU1580142542.USD","LU1997244956.HKD","IBBQ","LU2264538146.SGD","LU2242644610.SGD","LU0210536198.USD","LU0289739699.SGD","LU0109391861.USD","LU0949170426.SGD","SGXZ99366536.SGD","LU1831875114.USD","LU0057025933.USD","MEDX","LU0306807586.USD","LU1323610961.USD","LU1941712348.USD","LU0985320562.USD","LU1015430645.USD","LU0096364046.USD","LU1629891620.HKD","LU0557290698.USD","LU0820561818.USD","LU2125909247.SGD","LU0545562505.USD","IE00BWXC8680.SGD","LU2265009873.SGD","LU0320765992.SGD","LU1255011170.USD","IE00B031HY20.USD","LU2476274308.USD","LU0417516571.SGD","LU0889565916.HKD","LU2462591350.SGD","LU2347655073.USD","SG9999015986.USD","LU2462157665.USD","LU0061475181.USD","LU0971552673.USD","MHIP","LU0072461881.USD","IE00B3PB1722.GBP","HRTS","LU1732800096.USD","LU0140636845.USD","BMED","LU2237443549.SGD","LU2328871848.SGD","XLV","LU2491050154.USD","LU2468319806.SGD","600276","LU0471298777.SGD","LU0211331839.USD","LU0390134368.USD","LU0348784397.USD","LU0463099449.HKD","LU0348766576.USD","LU0965509283.SGD","SG9999014898.SGD","LU2237443895.HKD","LU1153584641.USD","LU0316494557.USD","LU0354030438.USD","LU1035773651.USD","LU1074936037.SGD","IE000F7OJYX1.SGD","NVO","03165","BNTX","LU2133065610.SGD","WDNA","LU0972486137.USD","LU0011850046.USD","LU2242652126.USD","LU0640476718.USD","GDOC","LU2237443382.USD","SG9999014914.USD","LU0640478417.SGD","LU1979441026.SGD","LLYX","LU1003077747.HKD","IBB","LU2361044949.HKD","LU0320765646.SGD","IE0034235071.USD","LU2168564222.USD","BK0060","LLYZ","LU2596442595.SGD","LU2129689605.HKD","LU0124676726.USD","IE00BVYPNV92.GBP","LU2097828557.USD","LU1720051017.SGD","LU0211327993.USD","LU2471134879.HKD","IE00BGHQF631.EUR","IE00BPRC5H50.USD","BK1161","LU0310800965.SGD","IE00BFSS7M15.SGD","LU2236285917.USD","BK0183","LU1226288170.HKD","LU1273509221.SGD","LU0289961442.SGD","IE0008369823.USD","LU0211328371.USD","LU0067412154.USD","LU0417517546.SGD","SG9999014575.USD","IE00BSNM7G36.USD","LU1400636574.HKD","LU0511384066.AUD","LU2471134796.USD","BK4588","IE0004445239.USD","GSK.UK","BK4550","IE000MB6IJN5.SGD","IE00B775H168.HKD","LU0244354667.USD","LU0980610538.SGD","LU0265550946.USD","LU2087625088.SGD","LU1720050803.USD","LU2360106947.USD","IE00BZ1G4Q59.USD","BK0239","LU1813983027.USD","LU0417516902.SGD","LU1623119135.USD","LU0266013472.USD","LU0047473722.SGD","LU0499090636.EUR","LU1894683264.USD","LU0029864427.USD","LU1201861249.SGD","IE0004445015.USD","IE00BZ08YS42.EUR","SG9999011175.SGD","LU0265550359.USD","BK4592","SG9999018857.SGD","LU2237443465.HKD","LU2168564065.EUR","IE0001KFT4U8.USD","LU1032466523.USD","LU1188198961.HKD","LU0820561909.HKD","LU0455707207.USD","LLII","LU1064131003.USD","LU1670711040.USD","LU2097828474.EUR","LU1226288253.USD","LU2028103732.USD","LU2580892789.USD","LU0310799852.SGD","LU1670710661.SGD","LU2211815571.USD","LU0289739343.SGD","LU0786609619.USD","SG9999017495.SGD","LU1880407132.USD","LU0964807845.USD","SG9999001176.USD","IE00BJJMRX11.SGD","LU1152091754.HKD","LU1196032939.SGD","LU0943347566.SGD","IE00BWDBJ516.SGD","LU0321505439.SGD","LU0920783379.SGD","IE0000B7K699.USD","LU0957799991.USD","LU0965508806.USD","LU1116320737.USD","LU1119994496.HKD","LU0912757837.SGD","IE00BJLML261.HKD","LU2087621335.USD","LU1718418525.SGD","LU1934455277.USD","SG9999014880.SGD","LU2433249047.HKD","LU2168564495.EUR","LU1302929846.USD","LU2746668974.SGD","TMED","LU0726765562.USD","LU1162221912.USD","LU1093756168.USD","LU0069063385.USD","LU0320765489.SGD","IYH","LU1035775433.USD","LU1267930813.SGD","LU1691799644.USD","LU0784384876.USD","LU1400636491.USD","LU1732799900.SGD","LU1280957306.USD","LU0070302665.USD","MEDI","LU0540923850.HKD","LU1355424745.HKD","LU0203345920.USD","LU1997245177.USD","BK4534","LU2237443622.USD","LU1863844665.USD","SGXZ57979304.SGD","LU0094547139.USD","LU0985481810.HKD","LU0861579265.USD","IE00B19Z3B42.SGD","LU1983299246.USD","LU1084165304.USD","LU0405327148.USD","SG9999001176.SGD","LU0225284248.USD","LU1699723380.USD","LU1934455863.HKD","SGXZ51526630.SGD","TBXU","SG9999002232.USD","IE000BZT7R73.USD","LU1366192091.USD","LU0942090050.USD","LU1807302812.USD","ABBV","AZN.UK","01093","LU0417516738.SGD","LU0857590862.USD","LU1551013342.USD","LU0345770308.USD","LU1244550494.USD","LU2750360641.GBP","LU2361045086.USD","IE0005OL40V9.USD","LU1585245621.USD","LU1839511570.USD","LU0256863902.USD","LU0320765059.SGD","LU1066051225.USD","SG9999014542.SGD","LU0306806265.USD","LU2362541513.USD","IE00BKPKM429.USD","IE00B42XCP33.USD","LU2023250330.USD","LU2168564149.EUR","LU0237698245.USD","LU0456855351.SGD","LU0545039389.USD","LU0880133367.SGD","LU0738911758.USD","LU1328615791.USD","LU0162691827.USD","LU1829250122.USD","IE0002141913.USD","LLY","LU2357305700.SGD","LU2471134952.CNY","SG9999015358.SGD","LU2461242641.AUD","RHHBY","LU2756315318.SGD","LU0058720904.USD","LU0345777659.USD","LU1244550221.USD","ELIL","LU0859254822.USD","NVOC","LU0827474353.SGD","LU1046234339.USD","LU1023059063.AUD","BK1521","LU1989772840.SGD","LU0661504455.SGD","SGXZ81514606.USD","SG9999015341.SGD","BK1587","LU0683600562.USD","LU0170899867.USD","LU2091194634.USD","LU0823416689.USD","LU1670756490.USD","IE00B1BXHZ80.USD","LU0128525689.USD","LU1868837300.USD","SG9999014906.USD","LU0607220059.USD","LU0072913022.USD","LU0006306889.USD","NVOH","IE00BQJZX424.USD","LU0795875169.SGD","LU1035777561.USD","IE00B3M56506.USD","IE00BK4W5L77.USD","LU2271345857.HKD","LU2456880835.USD","LU3187612489.SGD","SG9999014567.USD","LU0225771236.USD","LU1804176565.USD","LU0198837287.USD","IE00B5MMRT66.SGD","SGXZ31699556.SGD","LU1868836914.USD","LU1232071149.USD","LU1037948897.HKD","LU1670627923.USD","LU1267930730.SGD","LU1993786604.SGD","LU0174119429.USD","LU0648001328.SGD","LU2097828714.EUR","LU1720051108.HKD","LU2097828631.EUR","LU1153585028.USD","NVS","LU2476274720.SGD","BK4599","BBH","IHE","LU0689626769.HKD","IE00B7KXQ091.USD","SG9999015945.SGD","LU0526926950.USD","SG9999013999.USD","LU2417539215.USD","LU0353189763.USD","LU1883839398.USD","BK1574","LU1226287875.USD","LU0472753341.HKD","IE00BFSS8Q28.SGD","LU0787776722.HKD","00013","LU2148510915.USD","IE0034235188.USD","LU1571399168.USD","LU1961090484.USD","LU2023250843.SGD","BK1583","HK0000165453.HKD","LU0405327494.USD","LU0471298694.HKD","LU0432979614.USD","BMY","LU1868836591.USD","688331","JDOC","RXL","NVOX","LU1051770623.HKD","LU1061106388.HKD","LU1670710588.SGD","IE00BKPKM643.USD","IE00B4R5TH58.HKD","LU0997586515.USD","LU1244550577.SGD","LU0321505868.SGD","LU1974910355.USD","01801","IE00BVYPNW00.USD","LU0203202063.USD","IE00BJT1NW94.SGD","IE00BJJMRY28.SGD","BK0188","BK4581","BK4516","LU2361044865.SGD","688506","BK0028","LU0345777147.USD","LU1951186391.HKD","LU2089283258.USD","LU0466842654.USD","PJP","LU1152091168.USD","LU2106854487.HKD","LU2471134523.USD","IE00BK4W5M84.HKD","09926","LU0171293334.USD","LU2488822045.USD","IE00BZ08YR35.GBP","LU0314109678.HKD","LU1066053197.SGD","LU1989771016.USD","SG9999015978.USD","LU2552382215.SGD","LU1880407215.USD","LU1481600234.SGD","LU0047473722.EUR","PAWZ","LU2746668461.USD","BK1515","IE00B2B36J28.USD","LU0987226296.USD","LU1057294990.SGD","LU0348783233.USD","LU0385154629.USD","LU1069347547.HKD","LU0348825331.USD","LU2756315664.SGD","LU1487256676.USD","BK4007","LU0501845795.SGD","LU0784385840.USD","IE00B543WZ88.USD","IE00BZ08YT58.USD","IE00BLSP4452.SGD","LU0097036916.USD","BK1588","FTXH","LU0225283273.USD","LU1814569148.SGD","LU2552382058.USD","LU0820562030.AUD","LU2237443978.SGD","SG9999015952.SGD","BK4578","LU0161305163.EUR","LU0211326839.USD","LU2112291526.USD","LU0920840948.USD","SG9999014559.SGD","CANC","HCM","LU0964806797.USD","LU0887340254.USD","LU2237438978.USD","IE00BKVL7J92.USD","LU1104425308.USD","LU0052756011.USD","LU1794554557.SGD","LU2125154935.USD","LU1988902786.USD","IE00B19Z3581.USD","LU0345770993.USD","LU1645745479.HKD","LU1820825898.SGD","VHT","LU0267386448.USD","LU0208291251.USD","BK4139","LU1929549753.HKD","LU1670711123.USD","IE0009355771.USD","LU0158827948.USD","GB00BDT5M118.USD","LU0348767384.USD","LU2362541273.HKD","LU0158827781.USD","LU1960683339.HKD","OZEM","LU1430594728.SGD","LU0784385170.HKD","LU0348735423.USD","BK4533","LU0353189680.USD","LU1868837136.USD","LU2778985437.USD","LU0823434583.USD","FHLC","LU0997586432.USD","LU1301847155.USD","03692","ELIS","LU1863844749.USD","LU0757432116.USD","LU1917777945.USD","AGNG","BK1593","BK5011","LU2089284900.SGD","LU1236620750.USD","LU1145028129.USD","LU2355687059.USD","LU1267930490.SGD","SG9999002224.SGD","LU0792757196.USD","LU2602419157.SGD","LU1228905540.USD","LU1069344957.HKD","BK4551","BK4568","LU0238689110.USD","LU1008478684.HKD","REGN","LU0154236417.USD","LU0211326755.USD","LU1997245094.SGD","LU2023250504.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124840365","title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","url":"https://stock-news.laohu8.com/highlight/detail?id=1124840365","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124840365?lang=en_us&edition=fundamental","pubTime":"2026-10-02 17:11","pubTimestamp":1790932272,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","type":0,"news_type":0,"thumbnails":["https://news-video-sg.skytigris.cn/videos/covers/3059.webp"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Novartis Bets $7.8 Billion On MRNA Beyond Vaccines","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","BNTX","SNY","TEMC","RBOT","LLII","SBIO","DNA","ABT","TEMT","NVS","IDNA","JNJ","REGN","MRNY","NVOX","AMGN","LLY","GSK","MRNX","NVAX","GERM","GILD","LLYX","RXRX","TXG","ABSI","ELIL","GSKH","NVO","VERU","PFE","XBI","ABBV","NVOH","VIR","CRSP","BMY","MRK","BIIB","TEM","NVOC","AZN","BEAM","ELIS"],"isVideo":true,"video":{"duration":213,"video_url":"https://news-video-sg.skytigris.cn/videos/cdn/3059.mp4","video_thumbnail":"https://news-video-sg.skytigris.cn/videos/covers/3059.webp","audio_url":"https://static.tigerbbs.com/1c89c593761ab28aabf1a552eb3a775b.mp3","isAI":true},"gpt_icon":0},{"id":"2672273391","title":"The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind","url":"https://stock-news.laohu8.com/highlight/detail?id=2672273391","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672273391?lang=en_us&edition=fundamental","pubTime":"2026-10-01 08:00","pubTimestamp":1790812800,"startTime":"0","endTime":"0","summary":"For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose?Now it is changing to: What kind of weight are they losing?","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443549.SGD","GDOC","JDOC","LU0234572021.USD","LU0354030511.USD","LU2089284900.SGD","LU2168564065.EUR","LU0323591593.USD","LU2213496289.HKD","LU2750360997.AUD","BK4007","LU0053666078.USD","LU0114720955.EUR","SGXZ51526630.SGD","SG9999014898.SGD","LU0203201768.USD","LU2491050071.SGD","IE00B1BXHZ80.USD","IE00BJJMRX11.SGD","LU0456855351.SGD","LU0683600562.USD","BK4139","LU2023250330.USD","SG9999014906.USD","IE0009355771.USD","LU2271345857.HKD","LU1280957306.USD","LU2237443465.HKD","LU2362541273.HKD","LU2471134879.HKD","MEDI","IBBQ","IE00B7KXQ091.USD","GB00BDT5M118.USD","BK4581","LU0320765059.SGD","LU1035775433.USD","LU2746668461.USD","LU2168564495.EUR","IE00BK4W5M84.HKD","LU2236285917.USD","LU2471134952.CNY","LU2108987350.USD","LU0096364046.USD","LU0154236417.USD","LU0689472784.USD","LU0820561909.HKD","LU2087625088.SGD","IE0004445015.USD","LU0094547139.USD","LU2211815571.USD","LU2456880835.USD","BK4516","LU1691799644.USD","LU2112291526.USD","LU1366192091.USD","LU2362540622.SGD","SG9999018865.SGD","LU2491049909.HKD","LU0385154629.USD","LU0345770308.USD","LU1548497426.USD","SG9999013999.USD","LU0316494557.USD","TBXU","LU1069344957.HKD","LU1629891620.HKD","IE00B1XK9C88.USD","CURE","LU0466842654.USD","LU2361045086.USD","LU1983299246.USD","IE0001KFT4U8.USD","ELIS","LU0266013472.USD","LU1267930730.SGD","LU0109391861.USD","LU1551013425.SGD","LU1974910355.USD","LU2265009873.SGD","IE00BFTCPJ56.SGD","LU2491050154.USD","LU0158827781.USD","REGN","TMED","LU0106261372.USD","LU0225283273.USD","LU2461242641.AUD","LU1868836757.USD","LU0417517546.SGD","LU0353189680.USD","LU1804176565.USD","LU1712237335.SGD","LU2023251221.USD","PJP","LU0133085943.USD","IYH","LU2462157665.USD","VHT","LU0210536198.USD","BK4534","LU2471134523.USD","LU0320765992.SGD","LU0061475181.USD","IE00BWXC8680.SGD","LU0238689110.USD","LU2111349929.HKD","LU1064131342.USD","LU0122379950.USD","IE00BJJMRY28.SGD","PPH","IE00BKVL7J92.USD","LU2896262040.SGD","LU0345770993.USD","LLYZ","ELIL","LU2756315664.SGD","LU2417539215.USD","LU0889565916.HKD","BK4533","LU0882574139.USD","IE00BFSS8Q28.SGD","LU2237443978.SGD","LU2552382215.SGD","IE00BN29S564.USD","LU0289739699.SGD","THNR","LU0672654240.SGD","CANC","XLV","LU0823434740.USD","LLY","LU1127390331.HKD","LU2168563687.JPY","IHE","LU0820562030.AUD","LU0203202063.USD","LU1023059063.AUD","IE0004445239.USD","IE00BKDWB100.SGD","LU0820561818.USD","LU0471298777.SGD","MEDX","FHLC","LU0097036916.USD","LU0006306889.USD","LU0079474960.USD","LU0158827948.USD","LU1979441026.SGD","SGXZ31699556.SGD","LU2237443895.HKD","LU2462591350.SGD","LU2360106947.USD","LU0256863811.USD","LU1061106388.HKD","LLII","LU0943347566.SGD","LU2168564222.USD","LU2357305700.SGD","WDNA","LU0882574055.USD","IE00BJT1NW94.SGD","LU1232071149.USD","SG9999015952.SGD","SG9999014880.SGD","AGNG","BK4599","LU0353189763.USD","LU2468319806.SGD","LU1814569148.SGD","HRTS","RXL","LU2028103732.USD","NVOC","LU1057294990.SGD","LU2362541513.USD","LU1551013342.USD","IE00B4JS1V06.HKD","LU2063271972.USD","LU2089283258.USD","SG9999014914.USD","LU2023250504.SGD","LU0354030438.USD","LU2237443622.USD","IE00B4R5TH58.HKD","LU0640476718.USD","LU1868837136.USD","LU2471134796.USD","BK4585","LU0256863902.USD","LU1623119135.USD","LU1868837300.USD","LU2750360641.GBP","LU0198837287.USD","BK4588","LU2552382132.HKD","IE0002141913.USD","BK4532","IE0005OL40V9.USD","LU1989771016.USD","SGXZ57979304.SGD","SG9999015945.SGD","LU1868836914.USD","SGXZ99366536.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD","LU1868836591.USD","OZEM","NVOX","LU2756315318.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU0058720904.USD","ILDR","IXJ","LU1291159041.SGD","LU2361044865.SGD","NVOH","LU1720051108.HKD","LU2168564149.EUR","TRUH","LU0823416689.USD","LU2106854487.HKD","IE00BKPKM429.USD","LU2324357040.USD","NVO","LU2602419157.SGD","BBH","SG9999015986.USD","LU0471298694.HKD","LU2746668974.SGD","SG9999017495.SGD","SG9999015978.USD","LU2552382058.USD","LU0787776722.HKD","LU1720051017.SGD","LU1323610961.USD","LU0708995401.HKD","IE00BJLML261.HKD","LU0109394709.USD","LU0174119429.USD","LU1093756325.SGD","LU1988902786.USD","IE00BJJMRZ35.SGD","MHIP","SG9999001176.SGD","LU0786609619.USD","LU1917777945.USD","FTXH","SG9999001176.USD","LU0964807845.USD","SG9999018857.SGD","LU0823434583.USD","LLYX","LU2089984988.USD","LU2237443382.USD","IBB","LU2361044949.HKD","IE00B775H168.HKD","SGXZ81514606.USD","IE00BK4W5L77.USD","LU1145028129.USD","IE00BFSS7M15.SGD","LU2264538146.SGD","LU0432979614.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198490653","title":"23% Weight Loss, 27% Dropouts: How Strong Is Lilly's Phase 2 Combo, Really?","url":"https://stock-news.laohu8.com/highlight/detail?id=1198490653","media":"Options & Short Sell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198490653?lang=en_us&edition=fundamental","pubTime":"2026-10-01 07:58","pubTimestamp":1790812717,"startTime":"0","endTime":"0","summary":"","market":"other","thumbnail":"https://static.tigerbbs.com/8818ec487bcc6265f08776aa6beddf07","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8818ec487bcc6265f08776aa6beddf07"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"23% Weight Loss, 27% Dropouts: How Strong Is Lilly's Phase 2 Combo, Really?","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GPCR","RHHBY","NVOX","LLY","LLYX","NVOC","PFE","VKTX","ELIL","AMGN","NVOH","LLII","NVO","ELIS"],"isVideo":true,"video":{"duration":153,"video_url":"https://news-video-sg.skytigris.cn/videos/remotion/2943/render_2943_1790812083911.mp4","video_thumbnail":"https://community-static.tradeup.com/news/b064c13057afaef2771b273441eaa207","audio_url":"https://news-video-sg.skytigris.cn/videos/remotion/2943/tts/voiceover_61d6040c80e6655f.mp3","isAI":true},"gpt_icon":0},{"id":"2672787943","title":"Moderately bullish activity in Novo Nordisk with shares down 1.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2672787943","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672787943?lang=en_us&edition=fundamental","pubTime":"2026-10-01 04:45","pubTimestamp":1790801124,"startTime":"0","endTime":"0","summary":"Moderately bullish activity in Novo Nordisk (NVO), with shares down 40c near $37.91. Options volume roughly in line with average with 54k contracts...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-down-1-06-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderately-bullish-activity-in-novo-nordisk-with-shares-down-1-06-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVO","LU1093756168.USD","LU0154236417.USD","PPH","BK4007","NVOC","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4532","OZEM","LU1093756325.SGD","NVOH","BK4599","BK4585","NVOX","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672700786","title":"Novo Nordisk Opens a New Front in Cardiometabolic Care With Early-Stage Anti-Inflammatory Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2672700786","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672700786?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:31","pubTimestamp":1790785892,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Explores New Anti-Inflammatory Pathway for Heart and Metaboli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-opens-a-new-front-in-cardiometabolic-care-with-early-stage-anti-inflammatory-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-opens-a-new-front-in-cardiometabolic-care-with-early-stage-anti-inflammatory-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","NVOH","BK4532","NVOC","PPH","BK4585","NVO","BK4599","OZEM","LU0154236417.USD","NVOX","IE00BKVL7J92.USD","THNR","BK4007","LU1093756325.SGD","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672778609","title":"Novo Nordisk Tests Cagrisema Switch Strategy to Strengthen Its Diabetes Franchise","url":"https://stock-news.laohu8.com/highlight/detail?id=2672778609","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672778609?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:31","pubTimestamp":1790785861,"startTime":"0","endTime":"0","summary":"Novo Nordisk ($NVO) announced an update on their ongoing clinical study. Novo Nordisk Studies Key Switch From Ozempic to Cagrisema for Type 2 Diabe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-cagrisema-switch-strategy-to-strengthen-its-diabetes-franchise?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novo-nordisk-tests-cagrisema-switch-strategy-to-strengthen-its-diabetes-franchise?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0154236417.USD","BK4532","IE00BKVL7J92.USD","BK4588","BK4585","LU1093756168.USD","NVO","NVOC","BK4007","NVOH","OZEM","THNR","NVOX","LU1093756325.SGD","BK4599","IE00BZ1G4Q59.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672597786","title":"Novo Nordisk A/S Series B Stock Rises Wednesday, Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672597786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672597786?lang=en_us&edition=fundamental","pubTime":"2026-10-01 00:03","pubTimestamp":1790784180,"startTime":"0","endTime":"0","summary":"This article was automatically generated using Dow Jones technology.Shares of Novo Nordisk A/S Series B advanced 0.6% to DKK253.20 Wednesday on what proved to be an overall negative trading session for the stock market, with the OMX Nordic 40 Index falling 0.4% to 2,597.48.The stock's rise  snapped a two-day losing streak.The company closed DKK156.75 short of its 52-week high of DKK409.95, which the company reached on January 23, 2026.Trading volume was 7,931,061, compared to the 50-day average trading volume of 4,771,126.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4599","BK4585","IE00BKVL7J92.USD","LU1093756168.USD","BK4588","NVOC","THNR","LU0154236417.USD","NVOX","PPH","LU1093756325.SGD","NVO","IE00BZ1G4Q59.USD","BK4007","NVOH","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671783524","title":"Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2671783524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671783524?lang=en_us&edition=fundamental","pubTime":"2026-09-30 22:45","pubTimestamp":1790779502,"startTime":"0","endTime":"0","summary":"FACTBOX-Weight-loss drug developers line up to tap lucrative market as competition heats upSept 30 (Reuters)-The weight-loss drug market is booming, with biotech firms racing to capture a slice of the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4N45M19G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0006306889.USD","ELIS","GB00BDT5M118.USD","LU0203202063.USD","LU2552382215.SGD","LU2089283258.USD","LU0094547139.USD","LU0672654240.SGD","LU1720051108.HKD","LLY","LU2361044865.SGD","LU0466842654.USD","LU0683600562.USD","IXJ","XLV","LU0106261372.USD","LU1064131342.USD","SG9999015986.USD","LU0122379950.USD","LU2491049909.HKD","LU2211815571.USD","LU2461242641.AUD","BK4599","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU2106854487.HKD","LU1093756168.USD","IE00B4JS1V06.HKD","LU0354030438.USD","SG9999018857.SGD","LU2237443895.HKD","LU1979441026.SGD","RXL","LU0234572021.USD","LU0820561909.HKD","LU1814569148.SGD","ELIL","LU0210536198.USD","LU0417517546.SGD","LU2237443622.USD","LU2417539215.USD","LU2750360997.AUD","SG9999001176.SGD","LU0964807845.USD","LU2468319806.SGD","SGXZ51526630.SGD","LU0198837287.USD","LU1366192091.USD","LU2237443465.HKD","LU2471134796.USD","LU1127390331.HKD","LU2456880835.USD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2462591350.SGD","LU0882574055.USD","LU0689472784.USD","SG9999001176.USD","LU1804176565.USD","IE00B2B36J28.USD","CURE","IE00BFSS8Q28.SGD","LU2168563687.JPY","LU2746668461.USD","LU2111349929.HKD","LU2357305700.SGD","LU0786609619.USD","LU0787776722.HKD","LU2168564149.EUR","LU2756315318.SGD","SG9999015952.SGD","FHLC","IE00BKPKM429.USD","IE00BJT1NW94.SGD","LU0097036916.USD","LU2023250330.USD","LU2237438978.USD","IE0004445015.USD","LU0133085943.USD","LU0203201768.USD","LU2237443549.SGD","LU2491050154.USD","LU0061475181.USD","BK4585","BK4588","LU0316494557.USD","SGXZ31699556.SGD","IE00BK4W5M84.HKD","IE0004445239.USD","LU1691799644.USD","LU1712237335.SGD","SGXZ57979304.SGD","LU2028103732.USD","IE0001KFT4U8.USD","LU2471134879.HKD","WDNA","LU0114720955.EUR","LU0158827781.USD","IE00BK4W5L77.USD","LU2063271972.USD","LU1629891620.HKD","LU1983299246.USD","GDOC","OZEM","IE0005OL40V9.USD","LU2602419157.SGD","IE00BKVL7J92.USD","IHE","LU2552382132.HKD","LU2360106947.USD","IE0009355771.USD","LU0820562030.AUD","NVOH","LU2462157665.USD","LU1548497426.USD","LU1551013425.SGD","IE00BJJMRZ35.SGD","LU2213496289.HKD","LU1868837136.USD","LU1232071149.USD","LU2746668974.SGD","LU1868836757.USD","MEDX","LU0256863902.USD","LU0432979614.USD","LU1093756325.SGD","LU1323610961.USD","LU1868836914.USD","LU2168564222.USD","IE00BN29S564.USD","LU1057294990.SGD","FTXH","IE00BJJMRX11.SGD","IE00BJJMRY28.SGD","LU2168564495.EUR","LU0882574139.USD","LU1917777945.USD","LU0820561818.USD","LU0154236417.USD","SGXZ81514606.USD","LU0456855351.SGD","TMED","LU0345770993.USD","LU1061106388.HKD","LU1720051017.SGD","LU2089984988.USD","LU2265009873.SGD","NVO","LU2089284900.SGD","LU2237443382.USD","MEDI","IE00BFSS7M15.SGD","SG9999018865.SGD","THNR","LU0943347566.SGD","LU2168564065.EUR","LU1974910355.USD","HRTS","LU0096364046.USD","LU0385154629.USD","LU1623119135.USD","LU2237443978.SGD","LU0238689110.USD","LU1145028129.USD","LU2471134523.USD","PJP","LU0823434583.USD","BK4534","IE0002141913.USD","SGXZ99366536.SGD","LU2271345857.HKD","LU2023250504.SGD","AGNG","MHIP","BK4532","SG9999014898.SGD","LU2756315664.SGD","SG9999015978.USD","ILDR","JDOC","LU0320765992.SGD","LU2491050071.SGD","LU1035775433.USD","LU1023059063.AUD","TRUH","LU1868836591.USD","LU0058720904.USD","IE00B1XK9C88.USD","LU2236285917.USD","LU2896262040.SGD","LU1551013342.USD","LU2324357040.USD","IE00B7KXQ091.USD","LU0823434740.USD","LU1989771016.USD","LU1988902786.USD","SG9999014914.USD","LLII","LU2552382058.USD","LU1069344957.HKD","LU1267930730.SGD","LU0353189680.USD","SG9999013999.USD","IYH","LU0471298694.HKD","LU0174119429.USD","LU1291159041.SGD","IE00BJLML261.HKD","IE00BKDWB100.SGD","LU0079474960.USD","LU2023251221.USD","LU2750360641.GBP","NVOX","LU0320765059.SGD","BK4007","LU0471298777.SGD","LU2087625088.SGD","LLYX","LU0889565916.HKD","BK4533","LU2112291526.USD","BK4581","LU2361045086.USD","LU0708995401.HKD","LU2361044949.HKD","VHT","LU0640476718.USD","LU0323591593.USD","LU0109394709.USD","LU0345770308.USD","SG9999014906.USD","LU1280957306.USD","SG9999014880.SGD","LU0354030511.USD","IE00B775H168.HKD","LU0158827948.USD","LU0225283273.USD","CANC","NVOC","LU0353189763.USD","BK4516","SG9999015945.SGD","LU0109391861.USD","IE00BZ1G4Q59.USD","LLYZ","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU1868837300.USD","LU2108987350.USD","LU0266013472.USD","LU2264538146.SGD","LU2471134952.CNY","SG9999017495.SGD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671202417","title":"Novo Nordisk announces new data on CagriSema","url":"https://stock-news.laohu8.com/highlight/detail?id=2671202417","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671202417?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:46","pubTimestamp":1790772380,"startTime":"0","endTime":"0","summary":"The company states: “Novo Nordisk (NVO) announced new data on how CagriSema works inside both the brain and body, presented at the European Associa...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-new-data-on-cagrisema-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novo-nordisk-announces-new-data-on-cagrisema-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LU1093756325.SGD","NVO","NVOC","IE00BZ1G4Q59.USD","BK4585","BK4532","BK4007","LU1093756168.USD","NVOH","NVOX","LU0154236417.USD","THNR","IE00BKVL7J92.USD","PPH","BK4588","OZEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671270754","title":"Patients Switching to Novo Nordisk's Wegovy Pill from Shots Lose More Weight in Real-World Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2671270754","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671270754?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:45","pubTimestamp":1790761500,"startTime":"0","endTime":"0","summary":"Patients switching toNovo Nordisk's Wegovy pill from shots lose more weight in real-world studySept 30 -Patients who switched from weight-loss injections to Novo Nordisk'sNOVOb.COdaily Wegovy pill continued to lose weight, according to data unveiled at a medical meeting on Wednesday, as the Danish drugmaker seeks to defend its lead over US rival Eli LillyLLY.Nin the market for oral obesity treatments.Study participants lost an average of 4.1% of their body weight over three months after transitioning from injectable obesity therapies — including Wegovy and Lilly's Zepbound — to oral semaglutide, the active ingredient in Wegovy, as well as Ozempic.Patients lost an average of 4.0 kg  from a baseline weight of 221.6 pounds  after making the switch, and the proportion of participants classified as clinically obese dropped to 65.5% from 87.1% after three months, with nearly 41% shedding at least 5% of their body weight.\"There's been a lot of questions on can people be compliant to the pill?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45L0IH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU1093756325.SGD","BK4599","BK4585","LU1093756168.USD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4588","NVO","BK4007","THNR","NVOH","NVOC","LU0154236417.USD","OZEM","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176833437","title":"2026 Nobel Prize Preview: Scientists Behind GLP-1 Weight-Loss Drugs Emerge as Leading Contenders","url":"https://stock-news.laohu8.com/highlight/detail?id=1176833437","media":"Deep News","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176833437?lang=en_us&edition=fundamental","pubTime":"2026-09-30 16:00","pubTimestamp":1790755226,"startTime":"0","endTime":"0","summary":"The 2026 Nobel Prize laureates will be announced successively from October 5 to 12. In order to understand the list of hot candidates, The Scientist published scientists' predictions for the 2026...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELIS","FXH","PJP","ELIL","CURE","RSPH","OZEM","LLYX","FHLC","NVOH","NBDS","PINK","THNR","MEDI","JDOC","NVOX","LLII","TRUH","IYH","NVOC","XLVI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}